http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2109294-C1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1cb08167e0660a2c2c209b344008f78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_551abb7c81eb32ba14d17d89ac42b434 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate | 1994-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1998-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_520fd46c3181ca2972335d7db41e76dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ce6eccbd3eb2554794879d6d5e0bd1a |
publicationDate | 1998-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | RU-2109294-C1 |
titleOfInvention | Method to predict psoriasis flow |
abstract | FIELD: medicine, dermatology, diagnostics. SUBSTANCE: by studying catalase activity in patient's blood serum followed by analysis of the data obtained within a norm it is necessary to predict disease remission from 2 to 6 months, in case of increased values by 2 or more times against a norm remission period within 7-18 months is predicted. EFFECT: higher efficiency and simplification of prediction. 1 tbl |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2508903-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2594250-C2 |
priorityDate | 1994-11-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.